Washington Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $256K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $535K | Hold |
|
|||||
|
2024
Q1 | $568K | Hold |
|
|||||
|
2023
Q4 | $627K | Hold |
|
|||||
|
2023
Q3 | $575K | Hold |
|
|||||
|
2023
Q2 | $563K | Hold |
|
|||||
|
2023
Q1 | $632K | Hold |
|
|||||
|
2022
Q4 | $673K | Sell |
|
|||||
|
2022
Q3 | $695K | Hold |
|
|||||
|
2022
Q2 | $680K | Hold |
|
|||||
|
2022
Q1 | $632K | Hold |
|
|||||
|
2021
Q4 | $724K | Hold |
|
|||||
|
2021
Q3 | $634K | Hold |
|
|||||
|
2021
Q2 | $684K | Hold |
|
|||||
|
2021
Q1 | $619K | Hold |
|
|||||
|
2020
Q4 | $719K | Hold |
|
|||||
|
2020
Q3 | $624K | Buy |
|
|||||
|
2020
Q2 | $802K | Hold |
|
|||||
|
2020
Q1 | $549K | Hold |
|
|||||
|
2019
Q4 | $550K | Buy |
|
|||||
|
2019
Q3 | $243K | Hold |
|
|||||
|
2019
Q2 | $308K | Buy |
|